ZLSCF (ZYUS Life Sciences) Interest Expense : $-0.41 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ZYUS Life Sciences's interest expense for the three months ended in Sep. 2024 was $ -0.14 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.41 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ZYUS Life Sciences's Operating Income for the three months ended in Sep. 2024 was $ -2.70 Mil. ZYUS Life Sciences's Interest Expense for the three months ended in Sep. 2024 was $ -0.14 Mil. ZYUS Life Sciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ZYUS Life Sciences Interest Expense Historical Data

The historical data trend for ZYUS Life Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Interest Expense Chart

ZYUS Life Sciences Annual Data

Trend

Dec21

Dec22

Dec23

Interest Expense

-2.14

-3.86

-2.44

ZYUS Life Sciences Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial						-0.16	-	-0.14	-0.13	-0.14

ZYUS Life Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.41 Mil.

ZYUS Life Sciences (OTCPK:ZLSCF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ZYUS Life Sciences's Interest Expense for the three months ended in Sep. 2024 was $-0.14 Mil. Its Operating Income for the three months ended in Sep. 2024 was $-2.70 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was $2.06 Mil.

ZYUS Life Sciences's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

ZYUS Life Sciences did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

ZYUS Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (OTCPK:ZLSCF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ZYUS:Canada

Address

407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8

Website

https://www.zyus.com

ZYUS Life Sciences Corp is primarily engaged in the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada.

ZYUS Life Sciences Headlines

No Headlines